HIVE Deferred Long Term Liab vs Total Stockholder Equity Analysis
HIVE Stock | USD 2.52 0.07 2.70% |
HIVE Blockchain financial indicator trend analysis is much more than just examining HIVE Blockchain Tech latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HIVE Blockchain Tech is a good investment. Please check the relationship between HIVE Blockchain Deferred Long Term Liab and its Total Stockholder Equity accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HIVE Blockchain Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Deferred Long Term Liab vs Total Stockholder Equity
Deferred Long Term Liab vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HIVE Blockchain Tech Deferred Long Term Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between HIVE Blockchain's Deferred Long Term Liab and Total Stockholder Equity is -0.33. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of HIVE Blockchain Technologies, assuming nothing else is changed. The correlation between historical values of HIVE Blockchain's Deferred Long Term Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of HIVE Blockchain Technologies are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Deferred Long Term Liab i.e., HIVE Blockchain's Deferred Long Term Liab and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | -0.33 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from HIVE Blockchain's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HIVE Blockchain Tech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HIVE Blockchain Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. The current year's Selling General Administrative is expected to grow to about 23 M, whereas Tax Provision is forecasted to decline to about 315.7 K.
2023 | 2024 (projected) | Cost Of Revenue | 159.8M | 167.8M | Research Development | 41.0M | 39.2M |
HIVE Blockchain fundamental ratios Correlations
Click cells to compare fundamentals
HIVE Blockchain Account Relationship Matchups
High Positive Relationship
High Negative Relationship
HIVE Blockchain fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 29.1M | 178.3M | 452.3M | 196.1M | 225.5M | 236.8M | |
Short Long Term Debt Total | 5.1M | 30.9M | 43.3M | 35.4M | 40.7M | 42.8M | |
Other Current Liab | 830.7K | 73.1K | 1.0M | 4.3M | 3.9M | 4.1M | |
Total Current Liabilities | 7.2M | 9.9M | 26.2M | 21.9M | 25.2M | 26.4M | |
Total Stockholder Equity | 21.1M | 134.5M | 389.1M | 148.8M | 171.1M | 179.7M | |
Property Plant And Equipment Net | 8.9M | 24.7M | 190.1M | 98.2M | 112.9M | 118.6M | |
Net Debt | (73.1K) | (9.4M) | 38.0M | 31.0M | 35.7M | 37.5M | |
Retained Earnings | (173.2M) | (130.6M) | (60.2M) | (296.7M) | (267.0M) | (253.6M) | |
Accounts Payable | 2.1M | 3.5M | 12.4M | 6.9M | 7.9M | 4.9M | |
Cash | 5.1M | 40.3M | 5.3M | 4.4M | 5.0M | 5.3M | |
Non Current Assets Total | 10.8M | 70.8M | 252.0M | 113.6M | 130.7M | 137.2M | |
Non Currrent Assets Other | 1.6M | 45.5M | 61.5M | 15.4M | 17.7M | 18.2M | |
Cash And Short Term Investments | 5.1M | 41.3M | 22.3M | 7.2M | 8.3M | 6.8M | |
Net Receivables | 9.1M | 6.8M | 8.0M | 9.4M | 10.8M | 11.3M | |
Common Stock Shares Outstanding | 65.4M | 73.3M | 84.8M | 82.9M | 95.3M | 100.1M | |
Liabilities And Stockholders Equity | 29.1M | 178.3M | 452.3M | 196.1M | 225.5M | 236.8M | |
Other Current Assets | 3.5M | 57.5M | 176.8M | 75.3M | 86.5M | 90.9M | |
Other Stockholder Equity | 283.3M | 5.7M | 5.2M | 35.6M | 41.0M | 44.8M | |
Total Liab | 8.0M | 43.9M | 63.2M | 47.3M | 54.4M | 57.1M | |
Total Current Assets | 18.3M | 107.5M | 200.3M | 82.5M | 94.9M | 99.6M | |
Short Term Debt | 4.3M | 6.3M | 12.8M | 10.7M | 12.3M | 12.9M | |
Common Stock | 188.5M | 259.9M | 413.7M | 419.2M | 482.1M | 506.2M | |
Property Plant And Equipment Gross | 8.9M | 24.7M | 342.8M | 273.7M | 314.7M | 330.5M | |
Accumulated Other Comprehensive Income | 5.7M | 5.2M | 35.6M | 26.3M | 30.2M | 31.7M | |
Non Current Liabilities Total | 775.5K | 34.0M | 37.1M | 25.4M | 22.9M | 22.9M | |
Inventory | 3.5M | 57.5M | 170.0M | 65.9M | 75.8M | 41.6M | |
Short Term Investments | 3.5M | 981.7K | 17.0M | 2.9M | 2.6M | 2.5M | |
Net Tangible Assets | 21.9M | 21.1M | 133.9M | 388.7M | 447.0M | 469.4M | |
Net Invested Capital | 23.8M | 162.3M | 419.7M | 173.8M | 199.8M | 175.2M | |
Net Working Capital | 11.1M | 97.7M | 174.1M | 60.6M | 69.7M | 71.8M | |
Property Plant Equipment | 12.1M | 8.7M | 24.6M | 190.1M | 218.7M | 229.6M | |
Short Long Term Debt | 2.7M | 4.4M | 10.6M | 8.4M | 9.6M | 6.4M | |
Capital Stock | 188.5M | 259.9M | 413.7M | 419.2M | 482.1M | 323.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether HIVE Blockchain Tech is a strong investment it is important to analyze HIVE Blockchain's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HIVE Blockchain's future performance. For an informed investment choice regarding HIVE Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HIVE Blockchain Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for HIVE Stock analysis
When running HIVE Blockchain's price analysis, check to measure HIVE Blockchain's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HIVE Blockchain is operating at the current time. Most of HIVE Blockchain's value examination focuses on studying past and present price action to predict the probability of HIVE Blockchain's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HIVE Blockchain's price. Additionally, you may evaluate how the addition of HIVE Blockchain to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is HIVE Blockchain's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HIVE Blockchain. If investors know HIVE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HIVE Blockchain listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.217 | Earnings Share (0.45) | Revenue Per Share 1.121 | Quarterly Revenue Growth 1.183 | Return On Assets (0.07) |
The market value of HIVE Blockchain Tech is measured differently than its book value, which is the value of HIVE that is recorded on the company's balance sheet. Investors also form their own opinion of HIVE Blockchain's value that differs from its market value or its book value, called intrinsic value, which is HIVE Blockchain's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HIVE Blockchain's market value can be influenced by many factors that don't directly affect HIVE Blockchain's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HIVE Blockchain's value and its price as these two are different measures arrived at by different means. Investors typically determine if HIVE Blockchain is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HIVE Blockchain's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.